West German Study Group
Clinical trials sponsored by West German Study Group, explained in plain language.
-
Trial aims to tame aggressive breast cancer with gentler treatment
Disease control Recruiting nowThis study is for people with early-stage triple-negative breast cancer, a type known for being aggressive. It compares two drug combinations given before surgery to see if they can effectively eliminate the cancer while being easier to tolerate than standard chemotherapy. The tr…
Phase: PHASE3 • Sponsor: West German Study Group • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New drug trial aims to extend treatment time and quality of life for advanced breast cancer
Disease control Recruiting nowThis study is testing if adding the drug capivasertib to standard hormone therapy can help people with a specific type of advanced breast cancer stay on their treatment longer and maintain their quality of life. It is for adults whose cancer has continued to grow despite prior ho…
Phase: PHASE3 • Sponsor: West German Study Group • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Tracking 1,470 women for a decade to find the best breast cancer path
Knowledge-focused Recruiting nowThis study is a long-term registry that will follow 1,470 premenopausal women with early-stage, hormone-sensitive breast cancer for up to 10 years. It aims to understand how different standard treatment choices—like hormone therapy with or without ovarian suppression, and chemoth…
Sponsor: West German Study Group • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC